|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current assets | ||||||
| Cash | ||||||
| Prepaid expenses | ||||||
| Related party | ||||||
| Total prepaid expenses | ||||||
| Total current assets | ||||||
| Marketable securities held in Trust Account | ||||||
| TOTAL ASSETS | ||||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT | ||||||
| Current liabilities | ||||||
| Accounts payable and accrued expenses | ||||||
| Accrued expenses – related party | ||||||
| Related party | ||||||
| Total accrued expenses – related party | ||||||
| Accrued offering costs | ||||||
| Working capital loans – related party | ||||||
| Deferred consulting fees | ||||||
| Deferred legal fees | ||||||
| Total current liabilities | ||||||
| Deferred underwriting fee payable | ||||||
| Total Liabilities | ||||||
| Class A ordinary shares subject to possible redemption, 1,511,688 and 14,375,000 shares at redemption value of approximately $10.64 and $10.29 per share at September 30, 2026 and December 31, 2025, respectively | ||||||
| Shareholders’ Deficit | ||||||
| Ordinary shares, Value | ||||||
| Class A Ordinary Shares | ||||||
| Class B Ordinary Shares | ||||||
| Accumulated deficit | ||||||
| Total Shareholders’ Deficit | ||||||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT |
Loading...